These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10992374)

  • 1. Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline.
    Berruti A; Dogliotti L; Bitossi R; Fasolis G; Gorzegno G; Bellina M; Torta M; Porpiglia F; Fontana D; Angeli A
    J Urol; 2000 Oct; 164(4):1248-53. PubMed ID: 10992374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between bone metastatic cancer cells and sensory nerves in bone metastatic progression.
    Park SH; Tsuzuki S; Contino KF; Ollodart J; Eber MR; Yu Y; Steele LR; Inaba H; Kamata Y; Kimura T; Coleman I; Nelson PS; Muñoz-Islas E; Jiménez-Andrade JM; Martin TJ; Mackenzie KD; Stratton JR; Hsu FC; Peters CM; Shiozawa Y
    Life Sci Alliance; 2024 Dec; 7(12):. PubMed ID: 39266299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microphysiological systems as models for immunologically 'cold' tumors.
    Gaebler D; Hachey SJ; Hughes CCW
    Front Cell Dev Biol; 2024; 12():1389012. PubMed ID: 38711620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abscisic acid signaling through LANCL2 and PPARγ induces activation of p38MAPK resulting in dormancy of prostate cancer metastatic cells.
    Parajuli KR; Jung Y; Taichman RS
    Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38624012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase.
    Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X
    J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review.
    Van den Brande R; Cornips EM; Peeters M; Ost P; Billiet C; Van de Kelft E
    J Bone Oncol; 2022 Aug; 35():100446. PubMed ID: 35860387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcome of Patients with Bone Metastases in a Convalescent Rehabilitation Ward: A Case Series of Six Patients.
    Kobayashi M; Yoshikawa R; Harada R; Date A; Kobayashi Y; Kozawa S; Sakai Y
    Prog Rehabil Med; 2022; 7():20220022. PubMed ID: 35573804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raman Spectroscopy in Prostate Cancer: Techniques, Applications and Advancements.
    Gaba F; Tipping WJ; Salji M; Faulds K; Graham D; Leung HY
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-Body MRI vs. PET/CT for the Detection of Bone Metastases in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis.
    Zhan Y; Zhang G; Li M; Zhou X
    Front Oncol; 2021; 11():633833. PubMed ID: 34017680
    [No Abstract]   [Full Text] [Related]  

  • 10. High Serum Alkaline Phosphatase Flare after First-Line Androgen Deprivation Therapy Predicts Poor Prognosis in Metastatic Prostate Cancer Patients Treated with Second-Generation Androgen Receptor Targeted Therapy.
    Kojima S; Masuda H; Suyama T; Hou K; Mikami K; Araki K; Naya Y
    Prostate Cancer; 2021; 2021():5574067. PubMed ID: 33898066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic Spread in Prostate Cancer Patients Influencing Radiotherapy Response.
    Klusa D; Lohaus F; Furesi G; Rauner M; Benešová M; Krause M; Kurth I; Peitzsch C
    Front Oncol; 2020; 10():627379. PubMed ID: 33747899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of denosumab administration on bone metabolism for treatment of spinal metastasis.
    Kawanami K; Hirasawa A; Deie M
    J Orthop; 2021; 23():216-218. PubMed ID: 33603317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis.
    Vijayaraghavalu S; Gao Y; Rahman MT; Rozic R; Sharifi N; Midura RJ; Labhasetwar V
    Biomaterials; 2020 Jan; 227():119558. PubMed ID: 31654872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution and understanding of skeletal complication endpoints in clinical trials of tumors with metastasis to the bone.
    Hussain A; Lee RJ; Graff JN; Halabi S
    Crit Rev Oncol Hematol; 2019 Jul; 139():108-116. PubMed ID: 31170574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum alkaline phosphatase and 30-day mortality after surgery for spinal metastatic disease.
    Karhade AV; Thio QCBS; Ogink PT; Schwab JH
    J Neurooncol; 2018 Oct; 140(1):165-171. PubMed ID: 30173410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Bone Microenvironment in the Development of Painful Complications of Skeletal Metastases.
    Park SH; Eber MR; Widner DB; Shiozawa Y
    Cancers (Basel); 2018 May; 10(5):. PubMed ID: 29747461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.
    Nordstrand A; Bovinder Ylitalo E; Thysell E; Jernberg E; Crnalic S; Widmark A; Bergh A; Lerner UH; Wikström P
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity and enzyme inhibition studies of polyoxometalates and their chitosan nanoassemblies.
    Shah HS; Al-Oweini R; Haider A; Kortz U; Iqbal J
    Toxicol Rep; 2014; 1():341-352. PubMed ID: 28962250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements.
    Levitt DG; Levitt MD
    Int J Gen Med; 2016; 9():229-55. PubMed ID: 27486341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer.
    Adjei IM; Sharma B; Peetla C; Labhasetwar V
    J Control Release; 2016 Jun; 232():83-92. PubMed ID: 27090164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.